Register

Choose your Currency

* Marked fields are required

1Your Primary Details
2Your Talk Details
3Choose Package

Academic

Speaker Registration

On/Before
May 29, 2018
€380

On/Before
June 13 , 2018
€470

Final Call
June 24, 2018
€560

Special Registration

On/Before
May 29, 2018
€560

On/Before
June 13 , 2018
€660

Final Call
June 24, 2018
€760

Package A (Registration + 2 Nights Accommodation)

On/Before
May 29, 2018
€740

On/Before
June 13 , 2018
€830

Final Call
June 24, 2018
€920

Package B (Registration + 3 Nights Accommodation)

On/Before
May 29, 2018
€920

On/Before
June 13 , 2018
€1060

Final Call
June 24, 2018
€1150

Video Presentation

On/Before
May 29, 2018
€240

On/Before
June 13 , 2018
€330

Final Call
June 24, 2018
€420

Delegate

On/Before
May 29, 2018
€330

On/Before
June 13 , 2018
€420

Final Call
June 24, 2018
€510

Business

Speaker Registration

On/Before
May 29, 2018
€470

On/Before
June 13 , 2018
€560

Final Call
June 24, 2018
€650

Package A (Registration + 2 Nights Accommodation)

On/Before
May 29, 2018
€830

On/Before
June 13 , 2018
€920

Final Call
June 24, 2018
€1020

Package B (Registration + 3 Nights Accommodation)

On/Before
May 29, 2018
€1020

On/Before
June 13 , 2018
€1110

Final Call
June 24, 2018
€1200

Delegate

On/Before
May 29, 2018
€470

On/Before
June 13 , 2018
€560

Final Call
June 24, 2018
€650

Exhibitor

On/Before
May 29, 2018
€1380

On/Before
June 13 , 2018
€1830

Final Call
June 24, 2018
€2290

Student

Delegate

On/Before
May 29, 2018
€290

On/Before
June 13 , 2018
€380

Final Call
June 24, 2018
€470

YRF(Oral)/ Poster presentation

On/Before
May 29, 2018
€330

On/Before
June 13 , 2018
€420

Final Call
June 24, 2018
€510

E-Poster

Video presentation

On/Before
May 29, 2018
€290

On/Before
June 13 , 2018
€290

Final Call
June 24, 2018
€290

e- Poster

On/Before
May 29, 2018
€99

On/Before
June 13 , 2018
€99

Final Call
June 24, 2018
€99

ADD-On Registrations

Poster

On/Before
May 29, 2018
+ €100

Accompanying Person

On/Before
May 29, 2018
+ €249

Additional Two Nights

On/Before
May 29, 2018
+ €220

Additional Once Night

On/Before
May 29, 2018
+ €140

4Payment Info

Your Total Payment: 0.00 (All prices are in EUR only.)

Only Registration Includes:

  • Access to All Sessions
  • Coffee break during the conference
  • Handbook (proceedings) & Conference Kit
  • e- copy of the published abstract with DOI
  • Lunch during the conference
  • Certificate of Presentation

Package A Includes:

  • Above features (Only Registration) including the below
  • Breakfast during the Conference
  • 2 Nights’ accommodation (i.e. Sep 2nd & 3rd) of deluxe single/ double room at the conference venue

Package B Includes:

  • Above features (Only Registration) including the below
  • 3 Nights’ accommodation (i.e. Sep 2nd , 3rd & 4th ) of deluxe single/ double room at the conference venue

For Delegates

  • Access to All Sessions
  • Coffee break during the conference
  • Conference Kit
  • Lunch during the conference
  • Certificate of Participation

E-Posters:

  • The amount charged for E-Posters is to display the E-Posters only on website
  • The abstract will be published in conference proceeding book
  • The presenter is not required to be present in person at the conference
  • Soft copy of the e-poster Certificate

Group Discounts:

Note:

  • Here Conferences and Programs are announced to keep update our clients and to bookmark their dates. However, Registrations are not allowed before 12 months of the conference.
  • For cancellation policy PS: Terms & Conditions

Thank you for confirming your participation at In Vitro Diagnostics-2018 Conference. We eagerly waiting to meet you at London, UK.

International Conference on In Vitro Diagnostics | Sep 03-04 | 2018 | London | UK | IVD Confereces | IVD Meetings | IVD Workshops | IVD Presentations | IVD instruments |US IVDs | CDx | VD Technology | diagnostics technologies | in vitro diagnostic research | in vitro diagnostic development | in vitro diagnostic manufacturers | point of care testing | in vitro diagnostics | clinical laboratory tests | assay system components | Medical Devices | Biomedical devices | Biomedical technologies | In vitro diagnostic multivariate index assay | Protein biomarkers | IVDMIA | IVD group | Who Global Model Regulatory Framework | Medical Devices | in Vitro Diagnostic Medical Devices | Who Medical Device | Immunochemistry Assay Development | Assay Development Service | Bioanalytical applications | Biomarkers | Biosensors | Blood gas analyser | Blood Glucose Meters | Blood Screening | Immunochemistry Assay Development | Assay Development Service | Bioanalytical applications | Biomarkers | Biosensors | Blood gas analyser | Blood Glucose Meters | Blood Screening | CE mark for IVD | Circulating tumor cell (CTC) | Clinical Evidence | Clinical Instruments | Clinical Microbiology | Compaliance | Companion Diagnostics | Custom Antibody | Data Management | Diagnosis | Diagnotics | Digital PCR | DNA testing | Enzyme Linked Immunosorbent Assay (ELISA) | Gene Diagnostics | Genetic Testing | Haematological diagnostics | Haemoglobin Meters | Hematological Diagnosis | Immuno assay | Immunoassay | Immunochemical labeling kits | In Vitro Diagnostics | In vitro diagnostics applications | In Vitro Diagnostics Devices | In vitro diagnostics Manufacturing | In vitro diagnostics technology | In Vitro diagnostics tests | Industry Classification | IVD Classifications | IVD Design | IVD devices | IVD Instruments | IVD Manufacturers | IVD Market Drivers | IVD Market Intelligence | IVD Market Landscape | IVD Market Reports | IVD Market Statistics | IVD Reagents | IVD Regulation | IVD Tests | IVDS | Lab | on | a | chip | Lateral flow assays | Liquid biopsy | Microarray technology | Microfluidics | Mobile healthcare | Molecular assays | Molecular Diagnostics | Nanomaterial | based assays | Next | generation sequencing (NGS) | Noninvasive prenatal testing (NIPT) | Oncology Diagnosis | Paper | based assays | Patient self | testing | PCR | POCT | Point of Care Diagnostics | Point | of | care | Post Market Surveillance | Precision Medicine | Primary antibodies | Q PCR | Quality Control | Quality system in IVD | Radioimmunoassay | Reagents | Regulatory affair | Secondary antibodies | Sepsis markers | Signal enhancement | Smartphone | based devices | Stroke markers | Surface plasmon resonance | UDI implementation | UL mark for IVD | Companion Diagnostics | Disease detection | Disease diagnosis | Disease prevention | DNA Microarrays | DNA testing | Electrochemistry | ELISA | Exosomes | Gene Expression | Genetic testing | Haematological diagnostics | Immuno assay | Immunoassays | In Vitro Diagnostics | In Vitro diagnostics tests | Infectious disease | IVD | Liquid biopsy | Micro Array | Molecular assays | Molecular assays | Molecular Diagnostics | NGS | PCR | POCT | Point of Care Diagnostics | RT PCR | Screening | IVD Product Manufacturers | Group Purchase Organizations (GPOs) | Original Equipment Manufacturers (OEM) | Pathologists and Pathology Laboratories | Distributors of IVD Products | Hospitals and Clinics | Healthcare Institutions | Research Institutes | Market Research and Consulting Firms | Reagents & Kits | Instruments | Services | Data Management Software | Clinical Chemistry | Basic Metabolic Panel | Electrolyte Panel | Liver Panel | Lipid Profile | Renal Profile | Thyroid Function Panel | Specialty Chemical Tests | Immunochemistry/Immunoassay | Enzyme-Linked Immunosorbent Assay (ELISA) | Chemiluminescence Immunoassay (CLIA) | Fluorescence Immunoassay (FIA) | Colorimetric Immunoassay (CI) | Radioimmunoassays (RIA) | Rapid Tests | Western Blot | ELISPOT | Hematology | Coagulation & Hemostasis | Clinical Microbiology | Molecular Diagnostics (MDx) | Polymerase Chain Reaction (PCR) | Isothermal Nucleic Acid Amplification Technology (INAAT) | Microarrays | Hybridization | DNA Sequencing & Next-generation Sequencing | Other MDx technologies | Other Technologies | Global In Vitro Diagnostics Market | by Application | Diabetes | Infectious Diseases | Oncology/Cancer | Cardiology | Nephrology | Autoimmune Diseases | Drug Testing | HIV/Aids | Other Applications | Global In Vitro Diagnostics Market | by End User | Hospitals | Laboratories | Academic Institutes | Point-Of-Care Testing | Patient Self-Testing | End Users | immunoassays | point of care | molecular diagnostics | hematology | coagulation | microbiology | clinical techniques | microbiology | nstruments | reagents | services | data management systems | diabetes | oncology | cardiology | HIV/AIDS | autoimmune disease | nephrology | drug testing | IVD market | clinical laboratory testing | near-patient testing | self-testing | Prognosis of prediabetes and diabetes | Prediction of gestational diabetes | Treatment selection and monitoring | Guide development of islet sparing | disease-modifying drugs | Companion diagnostics | Direct assessment of pancreatic islet health | Improved efficiency and convenience compared to oral glucose test | Measurements complementary to glycemia | Early diagnosis of pheochromocytomas and other NET in plasma. | Accurate prognostic assessment | in vitro diagnostics | immunoassays | lateral flow assays | nanomaterial-based assays | biomarkers | lab-on-a-chip | microfluidics | electrochemistry | biosensors | signal enhancement | surface plasmon resonance | microarrays | paper-based assays | smartphone-based devices | mobile healthcare | point-of-care | bioanalytical applications | Antigen | AP (Alkaline Phosphatase) | Array | Assay diluent | Assay sensitivity | BCIP | Blocking | Blotting | Chemiluminescent substrate | Clinical sensitivity | Clinical specificity | Colorimetric substrate | Conjugate | Cross-reactivity | Detection limit | Diagnostic assay | Dilution | Dynamic range | ELISA (Enzyme-Linked ImmunoSorbant Assay) | Enzyme | Heterophilic interference | HRP (Horseradish Peroxidase) | Immunoassay | Immunoblotting | Immunohistochemistry | In situ hybridization (ISH) | Interference | IVD (In Vitro Diagnostics) | Matrix effect | Membrane | Microwell | Molecular diagnostics | Multiplexing | Non-specific binding | Passivating surface chemistry | pNPP | Protein stabilizers | Rheumatoid factor | Sample matrix interference | Signal | Substrate | Test performance | TMB | Western Blot | ID/AST Test | Auto ID | AST Systems | Manual ID | AST Systems | Blood Culture | Chromogenic Media | Rapid Micro,ID/AST Leader Market | Infectious Disease Immunoassays | Lab-Based | POC | Home Testing | Laboratory Infectious Disease | Immunoassays Sales by Disease,Hepatitis | HIV | Mycology | Parasitology | Respiratory | Sepsis | STDs | ToRCH | Infectious Disease Diagnostic Sales– North America | Western Europe | Japan | China | India | Latin America | ROW | Blood Screening Test Market Size and Company Market Share | Worldwide Cancer Diagnostic Market | Global Cancer IVD Market | Clinical Laboratory Services | Marketing Screening Tests for Prostate Specific Antige | Regulatory Strategy Expertise | FDA Negotiation | Clinical Trial Protocol Development | Clinical Site Recruitment | Clinical Trial Management | Statistical Planning and Analysis | Final Clinical Trial Reports | Regulatory Submissions | Quality Manufacturing Audits | Broad Selection of Clinical Diagnostic Analyzers | Abbott IMX | Abbott AxSym Plus | Abbott Architect | | Roche ElecySys 2010 | Siemens/Dade RXL | Tosoh AIA-600-II | Complement of Molecular Diagnostic Techniques | Full suite of CLSI Testing required by FDA-OIVD | IVD Test Technology Evaluation & Optimization | IVD Test Development & Optimization | Association of Medical Diagnostic Manufacturers | American Association for Clinical Chemistry | U.S. Food and Drug Administration | Clinical and Laboratory Standards Institute | Cancer Markers & PGx | Histology (In situ hybridization | HPV) | Microbiology/Virology (HAI; HIV; Hepatitis; GC/Chlamydia; Respiratory;Organism ID; Mycobacteria | TB; Others) | Blood Screening | Coagulation & PGx | Prenatal Testing | Inherited Diseases Testing | Tissue Typing | Organ Transplant Testing (HLA Typing) | Circulating Tumor Cells (CTCs) | Clinical Sequencing | Flow Cytometry | Cancer IVD Market | Cancer Test Services Market | Sequencing in Cancer Testing | Tissue Function Tests | PSA | CEA and Other Immunoassays | Flow Cytometry | Pap and HPV Testing | FOB and Other Rapid Tests | Molecular Oncology Assays | Tissue Microarrays | Methylated DNA | In situ hybridization (ISH) | Immunohistochemistry (IHC) | Circulating Tumor Cells | Companion Testing and CDX Products | Chromosome Analysis (Karyotyping) | Cytology/Histology Stains | Tests for Fecal Occult Blood | Immunoassays | Overview - Immunoassays | Immunoassay Instrument Platforms | Immunohistochemistry (IHC) | Flow Cytometry | Fluorescence in situ Hybridization (FISH) and Chromogenic in situ Hybridization(CISH) | Nucleic Acid Amplification Technologies | Analysis of Gene Expression Patterns (Gene Signatures) | Microarrays | Protein Microarrays | DNA Microarrays | Chromosomal Microarrays | Tissue Microarrays | Sequencing Technologies | Sanger Sequencing | Early Next Generation Sequencing Technologies | Sequencing by Synthesis (SBS) | Supported Oligonucleotide Ligation and Detection (SOLiD) | Ion Torrent Sequencing | True Single Molecule Sequencing (tSMS) | Single Molecule Real Time (SMRT) Sequencing | DNA Nanoball Sequencing | Nanopore Sequencing | Other Sequencing Technologies | Mass Spectrometry | Mass Spectrometry Technology | Research and Clinical Applications of Mass Spectrometry | Circulating Tumor DNA (Cell Free DNA) | Circulating Tumor Cells (CTCs) | Cell-Based Assays (Live Cell Cancer Tests) | Digital Pathology and Image Cytometry | Information Technology | Assess Risk of Developing Cancer | Cancer Screening | Cancer Screening – Pap Smear and Human Papillomavirus (HPV) Testing | Colorectal Cancer Screening | Prostate Cancer Screening | Screening for Other Cancers | Diagnosis/Prognosis/Monitoring of Cancer | Personalized Medicine/Companion Diagnostics/Precision Testing | Drug Metabolism | Predicting Response to Therapy | FIVE: CANCER DIAGNOSTIC MARKETS | In Vitro Diagnostic Kits Marketed to Clinical Laboratories | Point-of-Care Tests for Cancer | Clinical Laboratory Test Services | Investments and Financing Agreements for Cancer Diagnostic Companies | Agreements with Other Companies | Acquisitions of Cancer Diagnostic Companies | Selected Other Agreements | Cancer Diagnostic Market Drivers | Advances in Technology Changing the Future of Cancer Diagnostics | Impact of Companion Diagnostic Tests | Limited Tissue from Biopsies for Growing Number of Cancer Tests | Laboratory Developed Tests and the FDA | Cost and Reimbursement Issues | Physician Education | Acceptance | and Use of New Cancer Tests | Competition | Future Prospects | In Vitro Cancer Diagnostics Market by Geographical Distribution | Clinical Laboratory Testing Market – Cancer Diagnostics | In Vitro Cancer Diagnostics Market Segments | Histology/Cytology | Immunoassays | Rapid Tests | Molecular (Nucleic Acid-Based) Assays | M Genomics Ltd. | 20/20 GeneSystems | Inc. | AB SCIEX | Abbott Laboratories | Abcodia Ltd. | Abingdon Health Ltd | Abnova Corporation | ACT Genomics Co. | Ltd. | Adaptive Biotechnologies Corporation | Admera Health (a GENEWIZ company) | Advanced Cell Diagnostics | Affymetrix | Inc. | Agena Bioscience Inc. | Agendia NV | Agilent Technologies Inc. | Alere Inc. | Ambry Genetics Corp. | Amoy Diagnostics Co. | Ltd. | ANGLE plc | ApoCell | Inc. | Applied Proteomics | Inc. | Applied Spectral Imaging | Inc. | Arbor Vita Corporation | ARKRAY | Inc. | ARUP Laboratories | Astra Biotech GmbH | Asuragen | Inc. | AsymmetRx Medical | Inc. | Atossa Genetics Inc. | AutoGenomics | Inc | Avant Diagnostics | Inc. (formerly Arrayit Diagnostics Inc.) | Axela | Inc | AXO Science | Beckman Coulter | Inc. (subsidiary of Danaher Corporation) | Becton | Dickinson and Company (BD) | BGI-Shenzhen | The Binding Site Group Ltd. | Biocare Medical | LLC | Biocartis SA | Biocept | Inc. | Biodesix | Inc. | BioFluidica | BioGenex | Biological Dynamics Inc. | BioMarker Strategies | bioMérieux SA | BioMosaics | Bio-Rad Laboratories | Inc. | Bio-Reference Laboratories | Inc. (BRLI) | BioSystems | bioTheranostics (a bioMérieux company) | Biotype Diagnostic GmbH | BioView Ltd | Boditech Med Inc. | Cancer Genetics | Inc. | Canopus Bioscience Ltd. | Caprion | Inc. | Caris Life Sciences | Castle Biosciences | Inc. | CDx Diagnostics | Celerus Diagnostics | Inc. | Cellmid Ltd. | Centogene AG | Cepheid | Cernostics | Cirdan Imaging Ltd | Clarient Diagnostic Services | Inc. (a GE Healthcare company) | Clearbridge BioMedics Pte Ltd | Color Genomics | Inc. | Counsyl | Inc. | Cube Dx GmbH | Cynvenio Biosystems | Inc. | CytoTest Inc. | Dako A/S (an Agilent company) | Danaher Corporation | DermTech | Inc. | DiaCarta | Inc. | DiaSorin S.p.A. | DiaTech Oncology | EDP Biotech Corporation | Eiken Chemical Co. | Ltd. | EntroGen | Inc. | Enzo Biochem | Inc | Enzo Life Sciences | Inc. | Enzo Clinical Labs | Inc. | Epic Sciences | Inc. | Epigenomics AG | Eutropics Pharmaceuticals | Exact Sciences Corporation | Exosome Diagnostics | Inc. | Fluxion Biosciences | Inc. | Foundation Medicine | Inc. | Fujirebio Inc. | Fujirebio Diagnositics | Inc. | GE Healthcare | Genalyte | Inc. | GeneCentric Diagnostics | Inc. | Genection | Inc. (an Invivoscribe company) | GeneDx | GeneNews Limited | Genetic Technologies Limited / Phenogen Sciences | Inc. (U.S. division) | GenomeDx Biosciences | Genomica S.A.U. | Genomic Health | Inc. | Genomic Vision | Genoptix (a Novartis company) | GenPath / GenPath Women’s Health and GenPath Oncology | Guardant Health | Inc. | HalioDx | Healgen Scientific LLC | Helomics Corporation | Hologic | Inc. | HTG Molecular Diagnostics | Inc. | Human Longevity | Inc. | Icellate AB | Ikonisys | Inc. | Illumina | Inc. | ImCare BioTech | Immunovia AB | IncellDx | Inc. | Inform Genomics | Inc. | Financings | Other Agreements | Inivata Ltd. | Innovations Exchange Pte Ltd (INEX) | Insight Genetics | Inc. | IntegraGen SA | Integrated Diagnostics | Inc. | Invitae Corporation | Invivoscribe Technologies | Inc. | Iris BioTechnologies Inc. | Janssen Diagnostics / Janssen Diagnostics BVBA | Janssen Diagnostics | LLC | Laboratory Corporation of America (LabCorp) / Integrated Genetics | Leica Biosystems Inc. (a Danaher company) | Leica Microsystems (a Danaher company) | Lifecode | Inc. | MagArray | Inc. | Martell Diagnostic Laboratories | Inc. | Matrix-Bio | Inc. | Mayo Medical Laboratories and Mayo Clinic | Medical & Biological Laboratories Co. | Ltd. (MBL) | MBL International Corporation | MDxHealth SA | Metamark Genetics | Inc. | MetaStat | Inc. | MolecularMD Corporation | Multiplicom NV | Myriad Genetics | Inc. | Myriad RBM | Inc. | NanoIVD | Inc. | NanoString Technologies | Inc. | NeoGenomics | Inc. / NeoGenomics Laboratories | NewGene Ltd. | New Oncology AG | Nuclea Biotechnologies | Inc. | Ohmx Corporation | Omnyx | Oncimmune Ltd. | Oncimmune (USA) LLC (acquired by HDL Inc.) | Health Diagnostic Laboratory | Inc. | OncoCyte Corporation | OncoDNA SA | OncoHealth Corp. | Oncolab | Inc. | Oncolys BioPharma Inc. | Oncompass GmbH | Onconome | Inc. | OncoPlex Diagnostics (OncoPlexDx) | Oncospire Genomics | OPKO Health | Inc. / OPKO Diagnostics | Orion Genomics | Ortho-Clinical Diagnostics | OvaGene Oncology Inc. | Oxford Cancer Biomarkers Ltd. | Oxford Gene Technology | Pacific Edge Limited | Pathway Genomics Corporation | Personal Genome Diagnostics | Inc. | PGXL Laboratories | Phenomenome Discoveries Inc. | Polymedco | Inc. | PreTect AS | PrognosDx Health | Inc. | Provista Diagnostics | Inc. | QIAGEN N.V. | QuanDx | Quanterix Corporation | QuantuMDx Group | Quest Diagnostics | RainDance Technologies | Inc. | Randox Laboratories Ltd | Rarecells SAS | Response Genetics | Inc. | Rheonix | Inc. | RiboMed Biotechnologies | Inc. | Roche | Rosetta Genomics Ltd. | ScheBo-Biotech AG | ScreenCell | Sequenom | Inc. | Siemens Healthcare Diagnostics | Symbiodx | Sysmex Corporation | TeloVISION | LLC | Theranostics Health Inc. | Thermo Fisher Scientific | Inc. | Tosoh Corporation | Tosoh Bioscience | Inc. | Transgenomic | Inc. | TrimGen Corporation | TrovaGene | Inc. | Vela Diagnostics | Ventana Medical Systems | Inc. (member of the Roche Group) | Veracyte | Inc. | Wako Diagnostics | Wako Pure Chemical Industries | Ltd. | | Abbott Diagnostics | IntelligentMDx Alliance | PLEX-ID | Iridica | Histology | Alere Inc. | Beckman Coulter | Inc. / Danaher | Lab Services | Sequencing | Genomics | Information Technology | Becton | Dickinson and Company (BD) | The BD MAX Enterprise | Oncology | HPV | Sequencing | Initiatives | Mass Spectrometry | Flow Spectrometry | Bio-Rad Laboratories | Inc. | Controls | Digital PCR | bioMérieux Inc | Expansion | Oncology | Molecular Strategy | Sequencing Service | Danaher Corporation | General Electric - GE Healthcare | Clarient Diagnostic Services | Inc. | Hologic | Inc. | Product News | The Gen-Probe Business | Panther System | Blood Bank | Quest Contract | QIAGEN N.V. | Personalized Healthcare | Infectious Disease Testing | Transplant Medicine and HAIs | HPV | Companion Diagnostics | Liquid Biopsy/CTC | Instrumentation Base | Rotor-Gene Q – Clinical Diagnostics | Sequencing | Exosomes | Information Technology | Collaborations | Forensics | Roche Diagnostics | New Enterprises | Global Access Program for HIV | Core Molecular Tests | STDs | A POC Enterprise – Liat | Prenatal and cfDNA | HPV | Blood Bank | Liquid Biopsy | Sequencing – Putting the Pieces Together | Siemens Healthcare Diagnostics | Histology | Molecular | Companion Diagnostics | Sequencing | China | Sysmex Corporation | Inostics GmbH | Intraoperative Test | Flow Cytometry | Thermo Fisher Scientific Inc. | Molecular Microbiology | Microbiology IT | Transplant | Quality Control | Mass Spectrometry | EIGHTEEN: COMPANY PROFILES: MAJOR MOLECULAR COMPANIES | Affymetrix Inc. | Agilent Technologies | Agilent in Genomics | PCR | Sequencing | Arrays | Sample Management | Mass Spectrometry | Expansion | Asuragen Inc. | Controls | Sample Collection | Sequencing | BGI | With Complete Genomics | BGI Projects | Cepheid | Hospital Acquired Infections (HAI) | TB | Infectious Diseases | Virology | Oncology | Eiken Chemical Co. | Ltd | Enzo Biochem Inc. | IP Situation | Illumina | Sequencing | Sequencing Kits | Sample Prep | IVD Business | Oncology | HLA Typing | IT | Forensics | CLIA Lab Service | Nanopore Sequencing | Sample to Insight | Making a Market | IP Situation | Life Technologies Corporation | Instrumentation and Applications | Liquid Biopsy | Sequencing | Life Technologies an IVD Company | Partnerships Worldwide | Life and Quidel Develop Diagnostics on the 7500 Fast Dx | Sepsis | HIV | Emerging Pathogens | Bacterial Typing | Personalized Medicine | Forensic | PerkinElmer | Inc. (PE) | Newborn Testing | Prenatal Testing | Sequencing | Mass Spectrometry | Information Technology | China | RainDance Technologies | Inc. | Market Expansion | NINETEEN: COMPANY PROFILES: PARTICIPANTS | AutoGenomics Inc. | Biocartis SA | Connectivity | Instrumentation | Collaborations | Idylla News | DiaSorin S.p.A | EKF Diagnostics Holdings Plc | ELITech Group | Epigenomics | Exosome Diagnostics | Inc. | Fluidigm Corporation | Fujirebio Diagnostics | Inc. | GenMark Diagnostics | Genome Diagnostics BV (GenDx) | Luminex Corporation | Business Expansion | MAGPIX Multiplexing | Next Generation NxTag | Product News | Menarini Diagnostics | Nanostring Technologies | Inc. | Alliances | LDTs | Pacific Biosciences of California | Inc. (PacBio) | Quidel Corporation | Lyra Product Line | Solana Molecular System | AmpliVue Product Line | Savanna (formerly Wildcat) | Acquisitions | Rubicon Genomics | Inc. | Transgenomic | Inc. | Alliances | Lab Services | Diagnostic Tools Division | TrovaGene | Inc. | WaferGen Bio-systems | Inc. | TWENTY: COMPANY PROFILES: GREAT EXPECTATIONS | Genomic Vision | GENOMICA S.A.U. | IncellDx | Inc. | Inivata | IntegenX Inc | Linkage Biosciences | Inc. | Savyon Diagnostics | Selventa | VolitionRx Limited | TWENTY-ONE: COMPANY PROFILES: NEWCOMERS | B Braun CeGaT | LLC | Canon BioMedical | Inc. | DestiNA Genomics Ltd | DiamiR | LLC | Randox Laboratories Ltd. | TWENTY-TWO: COMPANY PROFILES: TEST SERVICE PROVIDERS | 23andMe | What a Difference a Few Years Makes | The Move to Building a Research Company | Therapeutics Group | Ancestry | Outside the U.S. | Adaptive Biotechnologies Corporation | Agendia BV | AltheaDx Diagnostics | Inc. | Ambry Genetics | Oncology | Cardiac | Prenatal | Information Technology | ARUP Laboratories | Assurex Health | Athena Diagnostics | Bio-Reference Laboratories | Inc. (BRLI) | bioTheranostics | Cancer Genetics | Inc. (CGI) | The Response Genetics Acquisition | CareDx | Inc. | Caris Life Sciences | Centogene AG | Complete Genomics | Counsyl | Exact Sciences Corp. | Foundation Medicine Inc. | Genomic Health | Inc. | Market Uptake | Sequencing | Liquid Biopsy | Service Spin Off | Helomics Corporation | IntegraGen | Invitae Corporation | LabCorp | Laboratory Corporation of America | Infectious Diseases | Prenatal | Sequencing | Oncology | BRCA Saga | Information Technology | Forensic | Collaborations | Mayo Medical Laboratories | Information Technology | MDxHealth SA | Myriad Genetics | Product News | Companion Tests | Beyond Cancer | The U.S. Market | IP Update | Pathway Genomics Corporation | Quest Diagnostics | Oncology | Toxicology | Prenatal and Women’s Health | Market Expansion | Quest Partners for Market Accessibility | Rosetta Genomics Ltd. | Expansion | Veracyte | Inc. | TWENTY-THREE: COMPANY PROFILES: POINT OF CARE TEST SPECIALISTS | Atlas Genetics Ltd. | Biomeme | Inc. | DiAssess Inc | DNA Electronics Ltd (DNAe) | Enigma Diagnostics Limited | Entopsis | Epistem Holdings plc | InSilixa Inc. | Lucigen | PositiveID Corporation | QuantuMDx Group Limited | Rheonix | Inc. | Scanogen Inc. | Ubiquitome | Veredus Laboratories Pte Ltd | Xagenic